Pediatric movement disorders

Current Opinion in Neurology

Volumn 16, Issue 4, 2003, Pages 529-535

  Sanger, Terence D ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Ataxia; Athetosis; Childhood; Chorea; Diagnosis; Dystonia; Movement disorders; Myoclonus; Pediatric; Rigidity; Spasticity; Treatment; Tremor

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; BACLOFEN; BOTULINUM TOXIN; CLONAZEPAM; CLONIDINE; DANTROLENE; DOPA; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; PIRACETAM; TETRABENAZINE; TIZANIDINE; TRIHEXYPHENIDYL; VALPROIC ACID;

ATAXIA; ATHETOSIS; CHILD; CHOREA; CLINICAL TRIAL; DISEASE CLASSIFICATION; DISEASE SEVERITY; HUMAN; MOTOR DYSFUNCTION; MUSCLE HYPERTONIA; MUSCLE RIGIDITY; MYOCLONUS; PEDIATRICS; REVIEW; SPASTICITY; SYMPTOMATOLOGY; TREMOR;

EID: 0042626604     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wco.0000084233.82329.Oe     Document Type: Review

References (89)

1. Misbahuddin A, Warner TT. Dystonia: an update on genetics and treatment. Curr Opin Neurol 2001; 14:471-475.
2. West A, Periquet M, Lincoln S, et al. Complex relationship between Parkin mutations and Parkinson disease. Am J Med Genet 2002; 114:584-591.
3. West AB, Maraganore D, Crook J, et al. Functional association of the parkin gene promoter with idiopathic Parkinson's disease. Hum Mol Genet 2002; 11:2787-2792.
4. West AB, Lockhart PJ, O'Farell C, Farrer MJ. Identification of a novel gene linked to parkin via a bi-directional promoter. J Mol Biol 2003; 326:11-19.
5. Valente EM, Brancati F, Ferraris A, et al. PARK6-linked parkinsonism occurs in several European families. Ann Neurol 2002; 51:14-18.
6. Bentivoglio AR, Cortelli P, Valente EM, et al. Phenotypic characterisation of autosomal recessive PARK6-linked parkinsonism in three unrelated Italian families. Mov Disord 2001; 16:999-1006.
7. DeStefano AL, Lew MF, Golbe LI, et al. PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study. Am J Hum Genet 2002; 70:1089-1095.
8. Back SA, Han BH, Luo NL, et al. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci 2002; 22:455-463. This remarkable work provides the foundations for a new understanding of the relationship between prematurity, periventricular leukomalacia, and cerebral palsy.
9. Bandmann O, Wood NW. Dopa-responsive dystonia: the story so far. Neuropediatrics 2002; 33:1-5. This elegant summary of recent research on dopa-responsive dystonia underlines the importance of testing for this diagnosis in any child with an unexplained motor disorder.
10. Bandmann O, Valente EM, Holmans P, et al. Dopa-responsive dystonia: a clinical and molecular genetic study. Ann Neurol 1998; 44:649-656.
11. Bandmann O, Marsden CD, Wood NW. Atypical presentations of dopa-responsive dystonia. Adv Neurol 1998; 78:283-290.
12. Bandmann O, Nygaard TG, Surtees R, et al. Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity. Hum Mol Genet 1996; 5:403-406.
13. Pal PK, Leung J, Hedrich K, et al. [18F]-Dopa positron emission tomography imaging in early-stage, non-parkin juvenile parkinsonism. Mov Disord 2002; 17:789-794.
14. Palfi S, Leventhal L, Goetz CG, et al. Delayed onset of progressive dystonia following subacute 3-nitropropionic acid treatment in Cebus apella monkeys. Mov Disord 2000; 15:524-530.
15. He F, Zhang S, Qian F, Zhang C. Delayed dystonia with striatal CT lucencies induced by a mycotoxin (3-nitropropionic acid). Neurology 1995; 45:2178-2183.
16. Nishiyama N, Yukishita S, Hagiwara H, et al. Gene mutation in hereditary progressive dystonia with marked diurnal fluctuation (HPD), strictly defined dopa-responsive dystonia. Brain Dev 2000; 22 (Suppl 1):S102-S106.
17. Segawa M, Nishiyama N, Nomura Y. DOPA-responsive dystonic parkinsonism: pathophysiologic considerations. Adv Neurol 1999; 80:389-400.
18. Khan NL, Valente EM, Bentivoglio AR, et al. Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study. Ann Neurol 2002; 52:849-853.
19. Sanger TD, Delgado MR, Gaebler-Spira D, et al. Classification and definition of disorders causing hypertonia in childhood. Pediatrics 2003; 111:e89-e97.
20. Saint Hilaire MH, Burke RE, Bressman SB, et al. Delayed-onset dystonia due to perinatal or early childhood asphyxia. Neurology 1991; 41:216-222.
21. Burke RE, Fahn S, Gold AP. Delayed-onset dystonia in patients with "static" encephalopathy. J Neurol Neurosurg Psychiatry 1980; 43:789-797.
22. Campbell SK. Quantifying the effects of interventions for movement disorders resulting from cerebral palsy. J Child Neurol 1996; 11 (Suppl 1):S61-S70.
23. Lollar DJ, Simeonsson RJ, Nanda U. Measures of outcomes for children and youth. Arch Phys Med Rehabil 2000; 81:S46-S52.
24. Anthoney TR. Neuroanatomy and the neurologic exam. Ann Arbor: CRC Press; 1994.
25. Baraduc P, Wolpert DM. Adaptation to a visuomotor shift depends on the starting posture. J Neurophysiol 2002; 88:973-981.
26. Vetter P, Flash T, Wolpert DM. Planning movements in a simple redundant task. Curr Biol 2002; 12:488-491.
27. Wolpert DM, Ghahramani Z, Flanagan JR. Perspectives and problems in motor learning. Trends Cogn Sci 2001; 5:487-494.
28. Flanagan JR, King S, Wolpert DM, Johansaon RS. Sensorimotor prediction and memory in object manipulation. Can J Exp Psychol 2001; 55:87-95.
29. Koski L, Iacoboni M, Mazziotta JC. Deconstructing apraxia: understanding disorders of intentional movement after stroke. Curr Opin Neurol 2002; 15:71-77.
30. Butler JA. How comparable are tests of apraxia? Clin Rehabil 2002; 16:389-398.
31. Maassen B. Issues contrasting adult acquired versus developmental apraxia of speech. Semin Speech Lang 2002; 23:257-266.
32. Wambaugh JL. A summary of treatments for apraxia of speech and review of replicated approaches. Semin Speech Lang 2002; 23:293-308.
33. Nijland L, Maassen B, Van der Meulen S, et al. Coarticulation patterns in children with developmental apraxia of speech. Clin Linguist Phon 2002; 16:461-483.
34. Zoia S, Pelamatti G, Cuttini M, et al. Performance of gesture in children with and without DCD: effects of sensory input modalities. Dev Med Child Neurol 2002; 44:699-705.
35. Maruff P, Wilson P, Currie J. Abnormalities of motor imagery associated with somatic passivity phenomena in schizophrenia. Schizophr Res 2003; 60:229-238.
36. Wilson PH, Thomas PR, Maruff P. Motor imagery training ameliorates motor clumsiness in children. J Child Neurol 2002; 17:491-498.
37. Wilson PH, Maruff P, Ives S, Currie J. Abnormalities of motor and praxis imagery in children with DCD. Hum Mov Soi 2001; 20:135-159.
38. Surveillance of Cerebral Palsy in Europe. A collaboration of cerebral palsy surveys and registers. Surveillance of Cerebral Palsy in Europe (SCPE). Dev Med Child Neurol 2000; 42:816-824.
39. Nordmark E, Anderson G. Wartenberg pendulum test: objective quantification of muscle tone in children with spastic diplegia undergoing selective dorsal rhizotomy. Dev Med Child Neurol 2002; 44:26-33.
40. Jobin A, Levin MF. Regulation of stretch reflex threshold in elbow flexors in children with cerebral palsy: a new measure of spasticity. Dev Med Child Neurol 2000; 42:531-540.
41. Dietz V. Neurophysiology of gait disorders: present and future applications. Electroencephalogr Clin Neurophysiol 1997; 103:333-355.
42. Arnold AS, Blemker SS, Delp SL. Evaluation of a deformable musculoskeletal model for estimating muscle-tendon lengths during crouch gait. Ann Biomed Eng 2001; 29:263-274.
43. Comella CL, Leurgans S, Wuu J, et al. Rating scales for dystonia. A multicenter assessment. Mov Disord 2003; 18:303-312. This paper presents the Unified Dystonia Rating Scale and the Global Dystonia scale and compares them with the Burke-Fahn-Marsden dystonia scale [89]. Unfortunately the study did not evaluate the Barry-Albright dystonia scale [44] which has been tested more extensively in children.
44. Barry MJ, VanSwearingen JM, Albright AL. Reliability and responsiveness of the Barry-Albright Dystonia Scale. Dev Med Child Neurol 1999; 41:404-411.
45. Bourke-Taylor H. Melbourne Assessment of Unilateral Upper Limb Function: construct validity and correlation with the Pediatric Evaluation of Disability Inventory. Dev Med Child Neurol 2003; 45:92-96.
46. Randall M, Carlin JB, Chondros P, Reddihough D. Reliability of the Melbourne assessment of unilateral upper limb function. Dev Med Child Neurol 2001; 43:761-767.
47. Sakzewski L, Ziviani J, Van Eldik N. Test/retest reliability and inter-rater agreement of the Quality of Upper Extremities Skills Test (QUEST) for older children with acquired brain injuries. Phys Occup Ther Pediatr 2001; 21:59-67.
48. Rosenbaum PL, Walter SD, Hanna SE, et al. Prognosis for gross motor function in cerebral palsy: creation of motor development curves. JAMA 2002; 288:1357-1363. This longitudinal study showed that the GMFM and GMFCS rating scales can be used to make predictions of long-term functional outcomes in children. The five strata of the GMFCS effectively divide children into categories with differing outcomes as measured by the GMFM.
49. Boyd RN, Morris ME, Graham HK. Management of upper limb dysfunction in children with cerebral palsy: a systematic review. Eur J Neurol 2001; 8 (Suppl 5):150-166.
50. Engsberg JR, Ross SA, Olree KS, Park TS. Ankle spasticity and strength in children with spastic diplegic cerebral palsy. Dev Med Child Neurol 2000; 42:42-47.
51. Campbell WM, Ferrel A, McLaughlin JF, et al. Long-term safety and efficacy of continuous intrathecal baclofen. Dev Med Child Neurol 2002; 44:660-665.
52. Butler C, Campbell S. Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. AACPDM Treatment Outcomes Committee Review Panel. Dev Med Child Neurol 2000; 42:634-645.
53. McLaughlin J, Bjornson K, Temkin N, et al. Selective dorsal rhizotomy: meta-analysis of three randomized controlled trials. Dev Med Child Neurol 2002; 44:17-25. This paper reviews three randomized trials and shows that rhizotomy combined with physical therapy has a 'small but statistically significant advantage' over physical therapy alone.
54. Graham HK, Boyd RN, Fehlings D. Does intramuscular botulinum toxin A injection improve upper-limb function in children with hemiplegic cerebral palsy? Med J Aust 2003; 178:95-96.
55. Marsden CD, Marion MH, Quinn N. The treatment of severe dystonia in children and adults. J Neurol Neurosurg Psychiatry 1984; 47:1166-1173.
56. Burke RE, Fahn S. Double-blind evaluation of trihexyphenidyl in dystonia. Adv Neurol 1983; 37:189-192.
57. Burke RE, Fahn S, Marsden CD. Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl. Neurology 1986; 36:160-164.
58. Hoon Jr AH, Freese PO, Reinhardt EM, et al. Age-dependent effects of trihexyphenidyl in extrapyramidal cerebral palsy. Pediatr Neurol 2001; 25:55-58.
59. Jankovic J, Beach J. Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology 1997; 48:358-362.
60. Jankovic J, Orman J. Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias. Neurology 1988; 38:391-394.
61. Heggarty H, Wright T. Tetrabenazine in athetoid cerebral palsy. Dev Med Child Neurol 1974; 16:137-142.
62. Jankovic J. Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study. Ann Neurol 1982; 11:41-47.
63. Asher SW, Aminoff MJ. Tetrabenazine and movement disorders. Neurology 1981; 31:1051-1054.
64. Swash M, Roberts AH, Zakko H, Heathfield KW. Treatment of involuntary movement disorders with tetrabenazine. J Neurol Neurosurg Psychiatry 1972; 35:186-191.
65. Brunstrom JE, Bastian AJ, Wong M, Mink JW. Motor benefit from levodopa in spastic quadriplegic cerebral palsy. Ann Neurol 2000; 47:662-665.
66. Gros C, Frerebeau P, Perez-Dominguez E, et al. Long term results of stereotaxic surgery for infantile dystonia and dyskinesia. Neurochirurgia (Stuttg) 1976; 19:171-178.
67. Gros C, Frerebeau P, Privat JM, et al. Stereotaxic surgery of non-Parkinsonian dystonias and dyskinesias [in French]. Neurochirurgie 1976; 22:539-552.
68. Ghika J, Villemure JG, Miklossy J, et al. Postanoxic generalized dystonia improved by bilateral Voa thalamic deep brain stimulation. Neurology 2002; 58:311-313.
69. Tronnier VM, Fogel W. Pallidal stimulation for generalized dystonia. Report of three cases. J Neurosurg 2000; 92:453-456.
70. Coubes P, Roubertie A, Vayssiere N, et al. Treatment of DYT1-generalised dystonia by stimulation of the internal globus pallidus. Lancet 2000; 355:2220-2221.
71. Coubes P, Cif L, Azais M, et al. Treatment of dystonia syndrome by chronic electric stimulation of the internal globus pallidus. Arch Pediatr 2002; 9 (Suppl 2):84s-86s.
72. Albright AL, Barry MJ, Shafton DH, Ferson SS. Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol 2001; 43:652-657.
73. Albright AL, Barry MJ, Fasick P, et al. Continuous intrathecal baclofen infusion for symptomatic generalized dystonia. Neurosurgery 1996; 38:934-938; discussion 938-939.
74. Albright AL, Barry MJ, Painter MJ, Shultz B. Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy. J Neurosurg 1998; 88:73-76.
75. Thompson TP, Kondziolka D, Albright AL. Thalamic stimulation for choreiform movement disorders in children. Report of two cases. J Neurosurg 2000; 92:718-721.
76. Ross SA, Engsberg JR. Relation between spasticity and strength in individuals with spastic diplegic cerebral palsy. Dev Med Child Neurol 2002; 44:148-157. This paper strengthens the assertions made by Damiano et al. [78**] by showing the lack of a consistent relationship between strength and spasticity in children and adults with cerebral palsy.
77. Dodd KJ, Taylor NF, Damiano DL. A systematic review of the effectiveness of strength-training programs for people with cerebral palsy. Arch Phys Med Rehabil 2002; 83:1157-1164.
78. Damiano DL, Quinlivan J, Owen BF, et al. Spasticity versus strength in cerebral palsy: relationships among involuntary resistance, voluntary torque, and motor function. Fur J Neurol 2001; 8 (Suppl 5):40-49.
79. Damiano DL, Dodd K, Taylor NF. Should we be testing and training muscle strength in cerebral palsy? Dev Med Child Neurol 2002; 44:68-72. This paper and the other by Damiano et al. [78] point out the importance of strengthening exercises in cerebral palsy. These papers present a change in thinking as many authors had previously been concerned that increasing the strength in a spastic muscle might worsen spasticity and reduce function.
80. Bower E, Michell D, Burnett M, Campbell MJ, McLellan DL. Randomized controlled trial of physiotherapy in 56 children with cerebral palsy followed for 18 months. Dev Med Child Neurol 2001; 43:4-15.
81. Sokolov PL, Dremova GV, Samsonova SV. Hippotherapy as a method for complex rehabilitation of patients with late residual stage of infantile cerebral palsy [in Russian]. Zh Nevrol Psikhiatr Im S S Korsakova 2002; 102:42-45.
82. Heine B. Hippotherapy. A multisystem approach to the treatment of neuromuscular disorders. Aust J Physiother 1997; 43:145-149.
83. Nicholson JH, Morton RE, Attfield S, Rennie D. Assessment of upper-limb function and movement in children with cerebral palsy wearing lycra garments. Dev Med Child Neurol 2001; 43:384-391.
84. Gracies JM, Fitzpatrick R, Wilson L, et al. Lycra garments designed for patients with upper limb spasticity: mechanical effects in normal subjects. Arch Phys Med Rehabil 1997; 78:1066-1071.
85. Schaechter JD, Kraft E, Hilliard TS, et al. Motor recovery and cortical reorganization after constraint-induced movement therapy in stroke patients: a preliminary study. Neurorehabil Neural Repair 2002; 16:326-338.
86. Levy CE, Nichols DS, Schmalbrock PM, et al. Functional MRI evidence of cortical reorganization in upper-limb stroke hemiplegia treated with constraint-induced movement therapy. Am J Phys Med Rehabil 2001; 80:4-12.
87. Willis JK, Morello A, Davie A, et al. Forced use treatment of childhood hemiparesis. Pediatrics 2002; 110:94-96.
88. Boyd RN, Morris ME, Graham HK. Management of upper limb dysfunction in children with cerebral palsy: a systematic review. Eur J Neurol 2001; 8(Suppl 5):150-166.
89. Burke RE, Fahn S, Marsden CD, et al. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 1985; 35:73-77.